Article thumbnail

SUMOylation of DEC1 Protein Regulates Its Transcriptional Activity and Enhances Its Stability

By Yongde Hong, Xinrong Xing, Shujing Li, Hailian Bi, Chunhua Yang, Feng Zhao, Ying Liu, Xiang Ao, Alan K. Chang and Huijian Wu

Abstract

Differentiated embryo-chondrocyte expressed gene 1 (DEC1, also known as sharp2, stra13, or BHLHB2) is a mammalian basic helix-loop-helix protein that is involved in many aspects of gene regulation through acting as a transcription factor. Changes in DEC1 expression levels have been implicated in the development of cancers. Using COS-7 cell, we showed that DEC1 can be modified by the small ubiquitin-like modifiers, SUMO1, 2 and 3. Two major SUMOylation sites (K159 and K279) were identified in the C-terminal domain of DEC1. Substitution of either K159 or K279 with arginine reduced DEC1 SUMOylation, but substitution of both K159 and K279 abolished SUMOylation, and more protein appeared to be retained in the cytoplasm compared to wild-type DEC1. The expression of DEC1 was up-regulated after serum starvation as previously reported, but at the same time, serum starvation also led to more SUMOylation of DEC1. In MCF-7 cells SUMOylation also stabilized DEC1 through inhibiting its ubiquitination. Moreover, SUMOylation of DEC1 promoted its repression of CLOCK/BMAL1-mediated transcriptional activity through recruitment of histone deacetylase1. These findings suggested that posttranslational modification of DEC1 in the form of SUMOylation may serve as a key factor that regulates the function of DEC1 in vivo

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3148244
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2004). A novel autofeedback loop of Dec1 transcrip t i o ni n v o l v e di nc i r c a d i a nr h y t h m regulation.
  2. (2003). A superfamily of protein tags: ubiquitin, SUMO and related modifiers.
  3. (2002). Basic helixloop-helix protein DEC1 promotes chondrocyte differentiation at the early and terminal stages.
  4. (1998). Ciechanover A
  5. (2010). CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses.
  6. (2007). Concepts in sumoylation: a decade on.
  7. (2006). Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation.
  8. (2003). DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.
  9. (2008). DEC1 modulates the circadian phase of clock gene expression.
  10. (2003). DEC1 negatively regulates the expression of DEC2 through binding to the E-box in the proximal promoter.
  11. (2007). Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas.
  12. (2000). Dimerization and nuclear entry of mPER proteins in mammalian cells.
  13. (2004). DNA binding, but not interaction with Bmal1, is responsible for DEC1-mediated transcription regulation of the circadian gene mPer1.
  14. (2004). Expression of the gene for Dec2, a basic helix-loop-helix transcription factor, is regulated by a molecular clock system.
  15. (2004). Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas.
  16. (2004). Functional analysis of the basic helix-loop-helix transcription factor DEC1 in circadian regulation. Interaction with BMAL1.
  17. (2001). Gene structure and chromosomal location of a human bHLH transcriptional factor
  18. (2010). Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification.
  19. (2010). Influence of the estrous cycle on clock gene expression in reproductive tissues: effects of fluctuating ovarian steroid hormone levels.
  20. (2002). Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia.
  21. (2009). Liver X receptors (LXRalpha and LXRbeta) are potent regulators for hepatic Dec1 expression.
  22. (1999). mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop.
  23. (1997). Molecular characterization of the novel basic helix-loop-helix protein DEC1 expressed in differentiated human embryo chondrocytes.
  24. (1999). Nuclear protein transport pathways.
  25. (1997). Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helixloop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells.
  26. (2001). Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway.
  27. (2002). regulators of the mammalian molecular clock.
  28. (2009). Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
  29. (1998). Role of the CLOCK protein in the mammalian circadian mechanism.
  30. (2005). SHARP-2/ Stra13/DEC1 as a potential repressor of phosphoenolpyruvate carboxykinase gene expression.
  31. (2005). Something about SUMO inhibits transcription.
  32. (2000). Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms.
  33. (2002). Stra13 homodimers repress transcription through class B E-box elements.
  34. (2004). SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?
  35. (2004). SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins.
  36. (2009). SUMO interaction motifs in Sizn1 are required for promyelocytic leukemia protein nuclear body localization and for transcriptional activation.
  37. (2007). SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1.
  38. (1999). SUMO-1 modification activates the transcriptional response of p53.
  39. (2004). SUMO: a regulator of gene expression and genome integrity.
  40. (2008). Sumoylating and desumoylating enzymes at nuclear pores: underpinning their unexpected duties?
  41. (2009). The basic helix-loop-helix proteins differentiated embryo chondrocyte (DEC) 1 and DEC2 function as corepressors of retinoid X receptors.
  42. (2009). The CTCF insulator protein is posttranslationally modified by SUMO.
  43. (2009). The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in gastric cancer.
  44. (2004). The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in human tissues and tumours.
  45. (2004). The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers.
  46. (2004). The transcriptional repressor STRA13 regulates a subset of peripheral circadian outputs.
  47. (2003). The Ulp1 SUMO isopeptidase: distinct domains required for viability, nuclear envelope localization, and substrate specificity.
  48. (2007). Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1.
  49. (2000). Ubiquitin-mediated proteolysis: biological regulation via destruction.